Key result
Contrast-associated acute kidney injury (CA-AKIA definition) was associated with increased long-term mortality in patients with congestive heart failure (HR 1.44; 95% CI 1.19-1.74).
Why the study?
Different definitions of contrast-associated acute kidney injury have varying predictive effects on prognosis, but their relationship with long-term prognosis in CHF patients is underexplored.
Does the definition of contrast-associated acute kidney injury (CA-AKI) affect its predictive value for long-term mortality in patients with congestive heart failure undergoing coronary angiography?
Cohort (n=2,207)
No
Does the definition of contrast-associated acute kidney injury (CA-AKI) affect its predictive value for long-term mortality in patients with congestive heart failure undergoing coronary angiography?
Hazard Ratio: 1.44 (95% CI 1.19–1.74)
In patients with CHF undergoing coronary angiography, CA-AKI is associated with long-term mortality regardless of definition, but the definition using an increase ≥0.5 mg/dl or >25% within 72h yields a higher population attributable risk.
Both CA-AKI definitions associate with long-term mortality in CHF; supports vigilance but leaves optimal definition open for prospective study.
Background Different definitions of contrast-associated acute kidney injury (CA-AKI) have different predictive effects on prognosis. However, few studies explored the relationship between these definitions and long-term prognosis in patients with congestive heart failure (CHF). Thus, we aimed to evaluate this association and compared the population attributable risks (PAR) of different CA-AKI definitions. Methods This study enrolled 2,207 consecutive patients with CHF undergoing coronary angiography (CAG) in Guangdong Provincial People's Hospital. Two different definitions of CA-AKI were used: CA-AKIA was defined as an increase ≥.5 mg/dl or > 25% in serum creatinine (SCr) from baseline within 72 h after CAG, and CA-AKIB was defined as an increase of ≥.3 mg/dl or > 50% in SCr from baseline within 48 h after CAG. Kaplan-Meier methods and Cox regression were applied to evaluate the association between CA-AKI with long-term mortality. Population attributable risk (PAR) of different definitions for long-term prognosis was also calculated. Results During the 3.8-year median follow-up (interquartile range 2.1-6), the overall long-term mortality was 24.9%, and the long-term mortality in patients with the definitions of CA-AKIA and CA-AKIB were 30.4% and 34.3%, respectively. We found that CA-AKIA (HR: 1.44, 95% CI 1.19-1.74) and CA-AKIB (HR: 1.48, 95% CI 1.21-1.80) were associated with long-term mortality. The PAR was higher for CA-AKIA (9.6% vs. 8%). Conclusions Our findings suggested that CA-AKI was associated with long-term mortality in patients with CHF irrespective of its definitions. The CA-AKIA was a much better definition of CA-AKI in patients with CHF due to its higher PAR. For these patients, cardiologists should pay more attention to the presence of CA-AKI, especially CA-AKIA.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2022) conducted a cohort in Congestive heart failure (CHF) (n=2,207). Contrast-associated acute kidney injury (CA-AKI) vs. No CA-AKI was evaluated on Long-term mortality (HR 1.44, 95% CI 1.19-1.74). Contrast-associated acute kidney injury (CA-AKIA definition) was associated with increased long-term mortality in patients with congestive heart failure (HR 1.44; 95% CI 1.19-1.74).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: